-
Health Canada’s Action Plan on Medical Devices: Continuously Improving...
Despite the strong foundation of Canada’s existing Regulations, more can be done to improve the safety and effectiveness of medical devices and to optimize health outcomes for... -
Qualifying notice: Zepzelca
This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with Conditions... -
What we heard: Consultations on the policy on Listeria monocytogenes in...
Health Canada's Listeria policy is an important tool used to help prevent the introduction of the illness-causing bacteria, L. monocytogenes, into ready-to-eat foods that are... -
Submission 'Class'
For eligible submissions accepted into review on or after October 1, 2018, the submission 'class' added to the Lists of submissions currently under review. -
Novel food information: Event EF2-114 Pineapple
Health Canada has notified Del Monte Fresh Produce Company (Del Monte) that it has no objection to the food use of Event EF2-114 pineapple. The Department conducted a... -
Nutrient Value of Some Common Foods (T16)
The Nutrient Value of Some Common Foods (NVSCF) booklet. -
Supplemented foods: Lists of temporary marketing authorization letters (TMALs)
The lists in Table 1 outline foods that were issued a Temporary Marketing Authorization Letter (TMAL) as supplemented foods and are eligible for a transition period to come into... -
Proposed Re-evaluation Decision PRVD2022-06, Zoxamide and Its Associated...
Zoxamide is a fungicide registered for the control of fungal diseases on potatoes, grapes and onions (bulb). This document (PRVD2022-06,) presents the proposed re-evaluation... -
Notice: Submission Filing Requirements - Good Manufacturing Practices...
Evidence of Good Manufacturing Practices (GMP) for drug submissions. The goal of this revision is to better align the drug submission screening and review process with the Drug... -
Registration Decision RD2022-04, Sheep Fat, Trico, and Trico Garden
This decision is consistent with the Proposed Registration Decision PRD2022-02, Sheep Fat, Trico and Trico Garden. -
Roles and Responsibilities to Address Drug Shortages
The drug supply chain is highly integrated and interdependent. All stakeholders have important roles to play when it comes to addressing drug shortages. -
Federal actions on opioids to date
The Government of Canada's actions to address the opioid overdose crisis and help save lives, including government funding for projects, increased access to treatment and harm... -
Canadian Nutrient File - Database Structure
Health Canada document gives detailed information on the CNF database and the structure of the database. -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
Because cyanide is toxic to humans, a maximum acceptable concentration of 0.2 mg/L (200 µg/L) for free cyanide in drinking water has been set. -
Roles and responsibilities under WHMIS
The Workplace Hazardous Materials Information System (WHMIS) is Canada's hazard communication standard. Suppliers, employers and workers each have requirements under WHMIS. -
Anti-diversionary measures under Canada's Access to Medicines Regime
Canada's Access to Medicines Regime includes a number of measures to prevent diversion of drugs and medical devices to unintended markets. -
Cannabidiol (CBD)
There is increasing interest, both in Canada and worldwide, in CBD. CBD is a compound found in the cannabis plant. It is regulated in Canada under the Cannabis Act. -
Proposed Registration Decision PRD2020-17, Imazapyr, Habitat Aqua
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-17, Imazapyr, Habitat Aqua provides detailed... -
Guide on the requirements for providing information related to drug...
Health Canada is responsible for helping the people of Canada maintain and improve their health. This is done, in part, by our commitment and actions to help protect the... -
Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a...
Interim Order No. 2 Respecting Drugs, Medical Devices, and Foods for a Special Dietary Purpose in Relation to COVID-19 (Interim Order No. 2) was signed on March 1, 2021.